A mid-term estimate of 2018/2019 vaccine effectiveness to prevent laboratory confirmed A(H1N1)pdm09 and A(H3N2) influenza cases in Sicily (Italy).
This report aim to explore the mid-term virologic surveillance data of the 2018-2019 influenza season in Sicily and to estimate the effectiveness of seasonal influenza vaccine (VE) against A(H1N1)pdm09 and A(H3N2) influenza viruses. A test-negative design was used to evaluate influenza VE. In Sicily, almost all influenza infections were sustained by influenza type A viruses, of which 62.3% were A(H3N2) and 36.3% A(H1N1)pdm09. A reduction of laboratory confirmed influenza cases in Sicilian population immunized against influenza were observed. In particular, an overall significant protective values were observed for any influenza A viruses (Adj-VE = 44.0%; 95%CI: 11.2-64.7%), especially among 15-64 years old age group (Adj-VE = 59.5%; 95%CI: 0.03-83.1) and among the elderly (Adj-VE = 73.6%; 95% CI: 29.4-90.2).
PMID: 31427134 [PubMed - as supplied by publisher]
Source: Vaccine - Category: Allergy & Immunology Authors: Costantino C, Restivo V, Amodio E, Colomba GME, Vitale F, Tramuto F Tags: Vaccine Source Type: research
More News: Allergy & Immunology | Epidemics | Epidemiology | H1N1 | H3N2 | Influenza | Influenza Vaccine | Italy Health | Laboratory Medicine | Swine Flu (H1N1) Vaccine | Vaccines | Virology